Literature DB >> 9108299

Human cathepsin W, a putative cysteine protease predominantly expressed in CD8+ T-lymphocytes.

C Linnevers1, S P Smeekens, D Brömme.   

Abstract

A 750-bp fragment of a novel human cysteine protease has been identified from the dbEST databank. PCR cloning and DNA sequencing yielded a 1.38-kb full-length cDNA which encodes a polypeptide of 376 amino acids. The protein consists of a putative 21-residue signal peptide, a 106-residue propeptide and a 252-residue mature protein. The deduced amino acid sequence contains the highly conserved residues of the catalytic triad of papain-like cysteine proteases: cysteine, histidine, and asparagine. Furthermore, the protein sequence possesses two potential N-glycosylation sites: one in the propeptide and one in the mature protein. Comparison of the amino acid sequence of human cathepsin W with other human thiol-dependent cathepsins revealed a relatively low degree of similarity (21-31%). In contrast to cathepsins L, S, K, B, H and O, cathepsin W contains a 21-amino acid peptide insertion between the putative active site histidine and asparagine residues and an 8-amino acid C-terminal extension. This unique sequence may indicate that cathepsin W belongs in a novel subgroup of papain-like proteases distinct from that of cathepsin L- and B-like proteases. Northern blot analysis indicates a specific expression of cathepsin W in lymphatic tissues. Further analysis revealed predominant levels of expression in T-lymphocytes, and more specifically in CD8+ cells. The expression of the protease in cytotoxic T-lymphocytes may suggest a specific function in the mechanism or regulation of T-cell cytolytic activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9108299     DOI: 10.1016/s0014-5793(97)00118-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Quantification of cathepsins B and L in cells.

Authors:  R Xing; A K Addington; R W Mason
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

Review 2.  Cathepsin B as a cancer target.

Authors:  Christopher S Gondi; Jasti S Rao
Journal:  Expert Opin Ther Targets       Date:  2013-01-08       Impact factor: 6.902

3.  Upregulation of cathepsin W-expressing T cells is specific for autoimmune atrophic gastritis compared to other types of chronic gastritis.

Authors:  Doerthe Kuester; Michael Vieth; Ulrich Peitz; Stefan Kahl; Manfred Stolte; Albert Roessner; Ekkehard Weber; Peter Malfertheiner; Thomas Wex
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

Review 4.  Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer.

Authors:  Achilleas D Theocharis; Chrisostomi Gialeli; Panagiotis Bouris; Efstathia Giannopoulou; Spyros S Skandalis; Alexios J Aletras; Renato V Iozzo; Nikos K Karamanos
Journal:  FEBS J       Date:  2014-11-06       Impact factor: 5.542

5.  'Patchiness' and basic cancer research: unravelling the proteases.

Authors:  Surinder M Soond; Maria V Kozhevnikova; Andrey A Zamyatnin
Journal:  Cell Cycle       Date:  2019-06-24       Impact factor: 4.534

6.  Crystal structure of wild-type human procathepsin K.

Authors:  J Sivaraman; M Lalumière; R Ménard; M Cygler
Journal:  Protein Sci       Date:  1999-02       Impact factor: 6.725

7.  Nuclear cathepsin F regulates activation markers in rat hepatic stellate cells.

Authors:  Gunter Maubach; Michelle Chin Chia Lim; Lang Zhuo
Journal:  Mol Biol Cell       Date:  2008-07-30       Impact factor: 4.138

Review 8.  Cathepsins mediate tumor metastasis.

Authors:  Gong-Jun Tan; Zheng-Ke Peng; Jin-Ping Lu; Fa-Qing Tang
Journal:  World J Biol Chem       Date:  2013-11-26

9.  Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.

Authors:  G P Shi; R A Bryant; R Riese; S Verhelst; C Driessen; Z Li; D Bromme; H L Ploegh; H A Chapman
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

10.  Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation.

Authors:  Kithiganahalli N Balaji; Norbert Schaschke; Werner Machleidt; Marta Catalfamo; Pierre A Henkart
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.